Naganari Ohkura

Title: Naganari Ohkura: Innovator in Cancer Treatment

Introduction

Naganari Ohkura is a prominent inventor based in Suita, Japan. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions. With a total of 2 patents, her work focuses on targeting specific cancer cells to improve treatment outcomes.

Latest Patents

Ohkura's latest patents include a method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells. This invention provides a pharmaceutical composition for cancer treatment comprising an antibody against CCR8. Another notable patent is a method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8. This also involves a pharmaceutical composition for cancer treatment that includes an antibody against CCR8.

Career Highlights

Throughout her career, Naganari Ohkura has worked with esteemed organizations such as Shionogi & Company Limited and Osaka University. Her experience in these institutions has allowed her to advance her research and contribute to the development of effective cancer therapies.

Collaborations

Ohkura has collaborated with notable colleagues, including Tetsuya Yoshida and Yujiro Kidani. These partnerships have played a crucial role in her research endeavors and have helped to enhance the impact of her inventions.

Conclusion

Naganari Ohkura's innovative work in cancer treatment exemplifies her dedication to improving patient outcomes through targeted therapies. Her contributions to the field are significant and continue to inspire future research in oncology.